William J. Bruno
Overview
William Bruno is a partner in the Washington, D.C. office of Crowell & Moring, where he is a member of the firm’s Corporate Group. William’s practice focuses on general corporate and securities matters for public and private companies, including mergers and acquisitions, initial and follow-on securities offerings, complex commercial transactions, and corporate governance. William advises clients seeking to grow, collaborate, and secure new capital.
Career & Education
- Cornell University, B.A., 2002
- University of Pennsylvania Law School, J.D., 2010
- District of Columbia
- New York
- Massachusetts
- Pennsylvania
William's Insights
Firm News | 2 min read | 05.22.26
May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).
Client Alert | 5 min read | 12.30.25
Investor Advisory Committee Recommends SEC Disclosure Guidelines for Artificial Intelligence
Client Alert | 3 min read | 03.17.25
SEC Issues No-Action Letter Clarifying Accredited Investor Verification Under Rule 506(c)
Insights
"63rd Annual Corporate Counsel Institute," Northwestern Pritzker School of Law
|06.06.24
What Investors Need to Know About AMC’s APE Units: A Stock ‘Split On Steroids’
|08.17.22
The Wall Street Journal
- |
05.23.24
Crowell & Moring’s Data Law Insights
William's Insights
Firm News | 2 min read | 05.22.26
May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).
Client Alert | 5 min read | 12.30.25
Investor Advisory Committee Recommends SEC Disclosure Guidelines for Artificial Intelligence
Client Alert | 3 min read | 03.17.25
SEC Issues No-Action Letter Clarifying Accredited Investor Verification Under Rule 506(c)
